These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35508055)

  • 21. Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy.
    Hilvo M; Wallentin L; Ghukasyan Lakic T; Held C; Kauhanen D; Jylhä A; Lindbäck J; Siegbahn A; Granger CB; Koenig W; Stewart RAH; White H; Laaksonen R;
    J Am Heart Assoc; 2020 May; 9(10):e015258. PubMed ID: 32375553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between Plasmatic Ceramides Profile and AST/ALT Ratio: C14:0 Ceramide as Predictor of Hepatic Steatosis in Adolescents Independently of Obesity.
    Maldonado-Hernández J; Saldaña-Dávila GE; Piña-Aguero MI; Núñez-García BA; López-Alarcón MG
    Can J Gastroenterol Hepatol; 2017; 2017():3689375. PubMed ID: 28634575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.
    Laaksonen R; Ekroos K; Sysi-Aho M; Hilvo M; Vihervaara T; Kauhanen D; Suoniemi M; Hurme R; März W; Scharnagl H; Stojakovic T; Vlachopoulou E; Lokki ML; Nieminen MS; Klingenberg R; Matter CM; Hornemann T; Jüni P; Rodondi N; Räber L; Windecker S; Gencer B; Pedersen ER; Tell GS; Nygård O; Mach F; Sinisalo J; Lüscher TF
    Eur Heart J; 2016 Jul; 37(25):1967-76. PubMed ID: 27125947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study.
    Cheng JM; Suoniemi M; Kardys I; Vihervaara T; de Boer SP; Akkerhuis KM; Sysi-Aho M; Ekroos K; Garcia-Garcia HM; Oemrawsingh RM; Regar E; Koenig W; Serruys PW; van Geuns RJ; Boersma E; Laaksonen R
    Atherosclerosis; 2015 Dec; 243(2):560-6. PubMed ID: 26523994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography.
    Mantovani A; Bonapace S; Lunardi G; Canali G; Dugo C; Vinco G; Calabria S; Barbieri E; Laaksonen R; Bonnet F; Byrne CD; Targher G
    Diabetes Metab; 2020 Apr; 46(2):150-157. PubMed ID: 31386900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome.
    Warshauer JT; Lopez X; Gordillo R; Hicks J; Holland WL; Anuwe E; Blankfard MB; Scherer PE; Lingvay I
    Diabetes Metab Res Rev; 2015 Oct; 31(7):734-44. PubMed ID: 25959529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceramides are fuel gauges on the drive to cardiometabolic disease.
    Wilkerson JL; Tatum SM; Holland WL; Summers SA
    Physiol Rev; 2024 Jul; 104(3):1061-1119. PubMed ID: 38300524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of neutral sphingomyelinase 2 through hyperglycemia contributes to endothelial apoptosis via vesicle-bound intercellular transfer of ceramides.
    Zietzer A; Jahnel AL; Bulic M; Gutbrod K; Düsing P; Hosen MR; Dörmann P; Werner N; Nickenig G; Jansen F
    Cell Mol Life Sci; 2021 Dec; 79(1):48. PubMed ID: 34951654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma Ceramides and Risk of Impaired Lower-Extremity Function in Older Adults: A Nested Case-Control Study.
    Caballero FF; Struijk EA; Buño A; Rodríguez-Artalejo F; Lopez-Garcia E
    J Gerontol A Biol Sci Med Sci; 2021 Jun; 76(7):1280-1287. PubMed ID: 32756936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.
    Kasumov T; Li L; Li M; Gulshan K; Kirwan JP; Liu X; Previs S; Willard B; Smith JD; McCullough A
    PLoS One; 2015; 10(5):e0126910. PubMed ID: 25993337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk and coronary atherosclerotic plaques detected by multidetector computed tomography: Framingham and SCORE risk models underestimate coronary atherosclerosis in the symptomatic low-risk Turkish population.
    Canpolat U; Yorgun H; Aytemir K; Hazrolan T; Kaya EB; Ateş AH; Dural M; Gürses KM; Sunman H; Tokgözoğlu L; Kabakç G; Oto A
    Coron Artery Dis; 2012 May; 23(3):195-200. PubMed ID: 22327064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated ceramides 18:0 and 24:1 with aging are associated with hip fracture risk through increased bone resorption.
    Kim BJ; Lee JY; Park SJ; Lee SH; Kim SJ; Yoo HJ; Rivera De Pena SI; McGee-Lawrence M; Isales CM; Koh JM; Hamrick MW
    Aging (Albany NY); 2019 Nov; 11(21):9388-9404. PubMed ID: 31675352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population.
    Chathoth S; Ismail MH; Alghamdi HM; Zakaria HM; Hassan KA; Alshomimi S; Vatte C; Cyrus C; Alsaif HS; Mostafa A; Shaaban H; Al Ali A
    Lipids Health Dis; 2022 Feb; 21(1):24. PubMed ID: 35184720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of recent ceramide-based coronary risk prediction scores in cardiovascular disease patients.
    Leiherer A; Mündlein A; Laaksonen R; Lääperi M; Jylhä A; Fraunberger P; Drexel H
    Eur J Prev Cardiol; 2022 May; 29(6):947-956. PubMed ID: 34417607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Wine and Tyrosol on the Lipid Metabolic Profile of Subjects at Risk of Cardiovascular Disease: Potential Cardioprotective Role of Ceramides.
    Rodríguez-Morató J; Boronat A; Serreli G; Enríquez L; Gomez-Gomez A; Pozo OJ; Fitó M; de la Torre R
    Antioxidants (Basel); 2021 Oct; 10(11):. PubMed ID: 34829550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Circulating Ceramides With Cardiac Structure and Function in the Community: The Framingham Heart Study.
    Nwabuo CC; Duncan M; Xanthakis V; Peterson LR; Mitchell GF; McManus D; Cheng S; Vasan RS
    J Am Heart Assoc; 2019 Oct; 8(19):e013050. PubMed ID: 31549564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating ceramide ratios and risk of vascular brain aging and dementia.
    McGrath ER; Himali JJ; Xanthakis V; Duncan MS; Schaffer JE; Ory DS; Peterson LR; DeCarli C; Pase MP; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    Ann Clin Transl Neurol; 2020 Feb; 7(2):160-168. PubMed ID: 31950603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of Ceramide, a Risk Factor for Coronary Artery Disease, in Human Coronary Plaques by Fluorescent Angioscopy.
    Uchida Y; Uchida Y; Kobayashi T; Shirai S; Hiruta N; Shimoyama E; Tabata T
    Circ J; 2017 Nov; 81(12):1886-1893. PubMed ID: 28674269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial Sphingolipid De Novo Synthesis Controls Blood Pressure by Regulating Signal Transduction and NO via Ceramide.
    Cantalupo A; Sasset L; Gargiulo A; Rubinelli L; Del Gaudio I; Benvenuto D; Wadsack C; Jiang XC; Bucci MR; Di Lorenzo A
    Hypertension; 2020 May; 75(5):1279-1288. PubMed ID: 32172624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma ceramides are associated with coronary atherosclerotic burden in patients with ST-segment elevation myocardial infarction.
    Pan W; Li L; Sun M; Wang C; Fang S; Yu B
    Int J Cardiol; 2020 Dec; 320():155-160. PubMed ID: 32800902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.